tm logo

Monitor this mark

View On USPTO

DILACOR XR
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 12 May 2023

Last Applicant/ Owned by

WATSON LABORATORIES, INC.

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

74249539 filed on 25th Feb 1992

Registration Number

1726980 registered on 27th Oct 1992

in the Principal Register

Correspondent Address

STEPHANIE K WADE

STEPHANIE K. WADE

2100 PENNSYLVANIA AVE. NW

WASHINGTON DC 20037

Filing Basis

1. use application currently

Disclaimer

NO DATA

DILACOR XR

cardiovascular preparation particularly useful for the treatment of hypertension

Classification Information

Class [005]
Pharmaceutical Products

cardiovascular preparation particularly useful for the treatment of hypertension

First Use Date in General

03rd Oct 1991

First Use Date in Commerce

03rd Oct 1991

Specimens

DILACOR XR specimenDILACOR XR specimenDILACOR XR specimenDILACOR XR specimen

Mark Details

Serial Number

No 74249539

Mark Type

No Service/Collective Mark

Attorney Docket Number

No W1715.0047

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
12th May 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
27th Oct 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
16th Oct 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
28th Jun 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
28th Jun 2012REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
28th Jun 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27th Jun 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
18th Jun 2012TEAS SECTION 8 & 9 RECEIVED
21st Mar 2008CASE FILE IN TICRS
28th Dec 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED